Carotid stenting with embolic protection: Evolutionary advances

Expert Review of Medical Devices

Volumn 5, Issue 4, 2008, Pages 427-436

  Ansel, Gary M ^a,b   Jaff, Michael R ^c,d  

^a RIVERSIDE METHODIST HOSPITAL   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angioplasty; Carotid; Embolic; Filter; Protection; Stent; Stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ANGIOGRAPHY; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; BALLOON OCCLUSION; CAROTID ARTERY FLOW; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; EMBOLISM PREVENTION; EQUIPMENT DESIGN; FEASIBILITY STUDY; GOLD STANDARD; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MINIMALLY INVASIVE SURGERY; MORBIDITY; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; RISK REDUCTION; STENT; TREATMENT RESPONSE; ANGIOPLASTY; BRAIN EMBOLISM; EVIDENCE BASED MEDICINE; FILTRATION; INSTRUMENTATION; PROSTHESIS; RADIOGRAPHY; REVIEW; STROKE; TREATMENT OUTCOME;

BRESCIA;

ANGIOPLASTY; BALLOON OCCLUSION; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; EVIDENCE-BASED MEDICINE; FILTRATION; HUMANS; INTRACRANIAL EMBOLISM; PROSTHESIS DESIGN; STENTS; STROKE; TREATMENT OUTCOME;

EID: 58149129264     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.5.4.427     Document Type: Article

References (43)

1. American Heart Association. Heart disease and stroke statistics: 2003 update. American Heart Association, TX, USA. (2003).
2. Veith FJ, Amor M, Ohki T et al. Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders. J. Vasc. Surg. 33, S111-S116 (2001).
3. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N. Engl. J. Med. 325, 445-453 (1991).
4. Executive Committee for the Asymptomatic Carotid Atherosclerosis, Study. Endarterectomy for asymptomatic carotid artery stenosis, JAMA 273, 1421-1428 (1995).
5. Young B, Moore WS, Robertson JT et al. An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Artheriosclerosis Study. Stroke 12, 2216-2224 (1996).
6. Halliday A, Mansfield A, Marro J et al.; Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet 8, 1491-502 (2004).
7. Ravipari G, Aronow WS, Alin C et al. Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins. Am. J. Cardiol. 98, 1170-1171 (2006).
8. Goodney PP, Schermerhorn ML, Powell RJ. Current status of carotid stenting. J. Vasc. Surg. 43, 406-411 (2006).
9. Yao JS. Angioplasty and stenting for carotid lesions: an argument against. Adv. Surg. 32, 245-254 (1999).
10. Diethrich EB. Carotid endarterectomy is better than carotid artery stenting for asymptomatic patients. Pro position. Tex. Heart Inst. J. 33, 209-210 (2006).
11. The Crest Investigators. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J. Vasc. Surg. 40, 1106-1111 (2004).
12. Saflan RD, Bresnanhan JF, Jaff MR et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J. Am. Coll. Cardiol. 47, 2384-2389 (2006).
13. Naylor AR. Where next after SPACE and EVA-3S: 'the good, the bad and the ugly!'. Eur. J. Vasc. Endovasc. Surg. 33, 44-47 (2007).
14. Powell RJ. Pro: carotid angioplasty and stenting will be the first-line interventional therapy for stroke prevention in patients with extracranial carotid occlusive disease. J. Cardiothorac. Vasc. Anesth. 19, 539-541 (2005).
15. Chaturvedi S, Aggarwal R, Murugappan A. Results of carotid endarterectomy with prospective neurologist follow-up. Neurology 55(6), 769-772 (2000).
16. Leger AR, Neale M, Harris JP. Poor durability of carotid angioplasty and stenting for treatment of recurrent artery stenosis after carotid endarterectomy: an institutional experience. J. Vasc. Surg. 33, 1008-1014 (2001).
17. Gröschel K, Riecker A, Schulz JB, Ernemann U, Kastrup A Systematic review of early recurrent stenosis after carotid angioplasty and stenting. Stroke 36, 367-373 (2005).
18. Armstrong PA, Bandyk DF, Johnson BL et al. Duplex scan surveillance after carotid angioplasty and stenting: a rational definition of stent stenosis. J. Vasc. Surg. 46, 460-465 (2007).
19. AbuRahma AF, Maxwell D, Eads K et al. Carotid duplex velocity criteria revisited for the diagnosis of carotid in-stent restenosis. Vascular 15, 119-125 (2007).
20. Cazaban S, Maïza D, Coffin O, Radoux JM, Mai C, Wen HY. Surgical treatment of recurrent carotid artery stenosis and carotid artery stenosis after neck irradiation: evaluation of operative risk. Ann. Vasc. Surg. 17(4), 393-400 (2003).
21. Gasecki AP, Eliasziw M, Ferguson GG et al. Long-term prognosis and effect of endarterectomy in patiens with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion: Results from NASCET. J. Neurosurg. 83, 778-782 (1995).
22. Meyer FB, Piepgras DG, Fode NC. Surgical treatment of recurrent carotid artery stenosis. J. Neurosurg. 80, 781-787 (1994).
23. Goldstein LB, McCrory DC, Landsman PB et al. Multicenter review of preoperative risk factors for endarteretomy for asymptomatic carotid artery stenosis. Stroke 29, 750-753 (1998).
24. CAVATAS investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Lancet 357, 1729-1737 (2001).
25. Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N. Engl. J. Med. 351, 1493-1501 (2004).
26. Gray WA, Hopkins LN, Yadav JS et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J. Vasc. Surg. 44, 258-268 (2006).
27. White CJ, Iyer SS, Hopkins LN. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc. Interv. 67(4), 503-512 (2006).
28. Hobson RW 2nd, Howard VJ, Roubin GS et al. Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry funding. Curr. Control Trials Cardiovasc. Med. 2, 160-164 (2001).
29. Lin PH, Bush RL, Peden EK et al. Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. Am. J. Surg. 190, 850-857 (2005).
30. Ringileb PA, Allenberg J, Brückmann H et al; SPACE Collaborative Group. 30-day results from the SPACE trial of stent protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomized noninferiority trial. Lancet 368, 1239-1247 (2006).
31. Mas JL, Chatellier G, Beyssen B et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N. Engl. J. Med. 355, 1660-1671 (2006).
32. McPhee JT, Hill JS, Ciocca RG et al. Carotid endarterectomy was performed with lower stroke and death rates than carotid artery stenting in the United States in 2003 and 2004. J. Vasc. Surg. 46, 1112-1118 (2007).
33. Bosiers M, Peeters P, Deloose K et al. Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry). J. Cardiovasc. Surg. 46(3), 241-247 (2005).
34. Younis GA, Gupta K, Mortazavi A et al. Predictors of carotid stent restenosis. Catheter Cardiovasc. Interv. 69, 673-682 (2007).
35. Gurm HS, Yadav JS, Fayad P et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N. Engl. J. Med. 358, 1572-1579 (2008).
36. Kastsup, A, Groschel K, Krapf H et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices. A systematic review of the literature. Stroke 34, 813-819 (2003).
37. Ouriel K, Wholey MH, Fayad P et al. Feasibility trial of carotid stenting with or without an embolic protection device. J. Endovasc. Ther. 12, 525-537 (2005).
38. Antonius Carotid Endarterectomy, Angioplasty, and Stenting Study Group. Transcranial Doppler monitoring in angioplasty and stenting of the carotid bifurcation. J. Endovasc. Ther. 10, 702-71 (2003).
39. Eskandari MK. Design and development of mechanical embolic protection devices. Expert Rev. Med. Devices 3, 387-393 (2006).
40. Henry M, Polydorou A, Henry I et al. New distal embolic protection device the FiberNet 3 dimensional filter: first carotid human study. Catheter Cardiovasc. Interv. 69, 1026-1035 (2007).
41. Schmidt A, Diederich KW, Scheinert S et al. Effect of two different neuroprotection systems on microembolization during carotid artery stenting. J. Am. Coll. Cardiol. 44, 1966-1969 (1004).
42. Reimers B, Sievert H et al. Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J. Endovasc. Ther. 12, 156-165 (2005).
43. Rabe K, Sugita J, Gödel H, Sievert H. Flow-reversal device for cerebral protection during carotid artery stenting - acute and long-term results. J. Interv. Cardiol. 19, 55-62 (2006).